Ads
related to: non metastatic prostate cancer treatment- Need a Second Opinion?
Put Our Expertise to Work for You.
Get a Virtual Second Opinion Today.
- Second Opinion
In Need of a Second Opinion?
Our Cancer Answer Line Can Help
- Virtual Second Opinions
Get Peace of Mind from Home.
Review Your Diagnosis & Treatment.
- Schedule an Appointment
Schedule an Appointment Today
Call our Cancer Answer Line
- Need a Second Opinion?
Search results
Results from the WOW.Com Content Network
Enzalutamide, sold under the brand name Xtandi, is a nonsteroidal antiandrogen (NSAA) medication which is used in the treatment of prostate cancer. [2] [9] It is indicated for use in conjunction with castration in the treatment of metastatic castration-resistant prostate cancer (mCRPC), [2] nonmetastatic castration-resistant prostate cancer, [2] and metastatic castration-sensitive prostate ...
Apalutamide was first described in 2007, and was approved for the treatment of prostate cancer in February 2018. [8] [9] [10] [15] It is the first medication to be approved specifically for the treatment of non-metastatic castration-resistant prostate cancer. [2] [10] [9]
If the cancer has spread beyond the prostate, treatment options change significantly, so most doctors who treat prostate cancer use a variety of nomograms to predict the probability of spread. Treatment by watchful waiting/active surveillance, HIFU, external-beam radiation therapy, brachytherapy, cryosurgery, and surgery are, in general ...
“One study reported that consuming high amounts of fat from vegetable sources after diagnosis of non-metastatic prostate cancer was associated with lower risk of developing lethal disease ...
USUALLY FOR: Metastatic prostate cancer. Targeted therapies that block certain molecules or chemical reactions in tumor cells have been shown to help some men with metastatic prostate cancer ...
Prostate tumors were first described in the mid-19th century, during surgeries on men with urinary obstructions. Initially, prostatectomy was the primary treatment for prostate cancer. By the mid-20th century, radiation treatments and hormone therapies were developed to improve prostate cancer treatment.
Ads
related to: non metastatic prostate cancer treatment